Earnings History Data for Enliven Therapeutics, Inc. (ELVN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Enliven Therapeutics, Inc.

Enliven Therapeutics Inc. is a clinical-stage precision oncology company focused on the discovery and development of small molecule kinase inhibitors. The Company's lead product candidate includes ELVN-001 and ELVN-002. Enliven Therapeutics Inc., formerly known as Imara Inc., is based in Boulder, CO.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
14-03-2024	AH		ELVN	Enliven Therapeutics, Inc.	525.00	-0.47	-0.56	0.00	Enliven Therapeutics GAAP EPS of -$0.47 [3/14/2024 5:24 PM]	12.04	0.50 (4.33%)	11.54	0.0 (0.00%)	9.80 - 24.22	573,986	70,000	4,833
Enliven Therapeutics GAAP EPS of -$0.47 [3/14/2024 5:24 PM]
09-11-2023	AH		ELVN	Enliven Therapeutics, Inc.	515.00	-0.51	-0.49	0.00	Enliven Therapeutics GAAP EPS of -$0.51 [11/9/2023 5:42 PM]	11.42	-0.13 (-1.13%)	11.55	0.0 (0.00%)	10.89 - 25.34	71,505	50,000	1,704
Enliven Therapeutics GAAP EPS of -$0.51 [11/9/2023 5:42 PM]
11-05-2023	AH	4:40 PM ET (May 11)	ELVN	Enliven Therapeutics, Inc.	126.00	-0.80	-0.67	0.00	Enliven Therapeutics GAAP EPS of -$0.80 misses by $0.28 [5/11/2023 5:01 PM]	19.41	0.31 (1.62%)	19.10	0.0 (0.00%)	4.04 - 25.34	85,252	80,000	131
Enliven Therapeutics GAAP EPS of -$0.80 misses by $0.28 [5/11/2023 5:01 PM]